Navigation Links
CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
Date:8/28/2007

se, highlighting the need for improved therapies for the treatment of this disease.

About Belinostat (PXD101)

Belinostat is a promising small molecule HDAC inhibitor being investigated for its role in the treatment of a wide range of solid tumors and hematologic malignancies either as a single-agent, or in combination with other active anti-cancer agents, including carboplatin, paclitaxel, cis-retinoic acid, azacitidine and Velcade(R) (bortezomib) for Injection. HDAC inhibitors represent a new mechanistic class of anti-cancer therapeutics that target HDAC enzymes and have been shown to arrest growth of cancer cells (including drug resistant subtypes); induce apoptosis, or programmed cell death; promote differentiation; inhibit angiogenesis; and sensitize cancer cells to overcome drug resistance when used in combination with other anti-cancer agents.

Intravenous belinostat is currently being evaluated in multiple clinical trials as a potential treatment for cutaneous and peripheral T-cell lymphomas, B-cell lymphomas, AML, mesothelioma, soft tissue sarcoma, MDS, and liver, colorectal, and ovarian cancers, either alone or in combination with anti- cancer therapies. An oral formulation of belinostat is also being evaluated in a Phase I clinical trial for patients with advanced solid tumors. In August 2004, CuraGen signed a Clinical Trials Agreement with the NCI under which the NCI will sponsor several clinical trials to investigate belinostat for the treatment of various cancers, both as a single-agent and in combination chemotherapy regimens. In May 2005, TopoTarget announced the signing of a Cooperative Research and Development Agreement (CRADA) with the NCI to conduct preclinical and nonclinical studies on belinostat in order to better understand its anti-tumor activity and to provide supporting information for clinical trials.

About CuraGen

CuraGen Corporation (Nasdaq:

SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CuraGen Presents Update on Clinical Development Program for Belinostat
2. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
3. CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
4. Malvern initiates European user group meetings for chemical imaging
5. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
6. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
7. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... Germany , April 28, 2015 /PRNewswire/ ... et plus facile des problèmes pour les cliniques ... panne temporaire des appareils médicaux peut conduire à ... Ziehm Remote Service offre aux cliniciens un diagnostic ... de fonctionnement optimisé. Cette option est immédiatement disponible ...
(Date:4/28/2015)... Company plc (NYSE: PRGO ; TASE) today announced ... of $0.125 per share, payable on June 16, 2015 to ... From its beginnings as a packager of generic ... Ireland , has grown to become ... distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional ...
(Date:4/28/2015)... , April 28, 2015  Illnesses know no work schedule ... places of business. If you,ve ever woken up the morning ... sick as the proverbial dog, or if you,ve been putting ... how to fit it into your schedule, you,ve experienced this ... House Call Doctor Los Angeles offers an alternative for busy ...
Breaking Medicine Technology:Ziehm Imaging lance Ziehm Remote Service 2Your Health and Your Schedule Should not be at War 2
... DIEGO, Feb. 10, 2011 Awarepoint Corporation today announced ... (RTLS) Client Conference and User Group , Viewpoint | ... (Logo: http://photos.prnewswire.com/prnh/20100127/LA44915LOGO ) At this ... opportunity to connect with other hospitals to share information ...
... the leading meeting place for buyers and sellers of high-value ... of its second Latin American Green Exchange Conference, which returns ... held in September 2011, with further details to be announced ... success of the inaugural Informex Latin America conference in 2010, ...
Cached Medicine Technology:Awarepoint Announces First Annual RTLS Customer Conference and User Group Results and Highlights 2Awarepoint Announces First Annual RTLS Customer Conference and User Group Results and Highlights 3Awarepoint Announces First Annual RTLS Customer Conference and User Group Results and Highlights 4Second Annual Latin America 'Green Exchange Conference' Hosted by Informex Focuses on a Sustainable Future for Chemistry 2Second Annual Latin America 'Green Exchange Conference' Hosted by Informex Focuses on a Sustainable Future for Chemistry 3
(Date:4/28/2015)... The Lymphoma Research Foundation (LRF) – ... innovative lymphoma research and serving the lymphoma community through ... patient services – will once again return to the ... to host its Annual Golf Invitational. The event, which ... May 18, 2015. , The par-70, 7,008-yard is ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Dr. Jeffrey Allred ... Instead of sending patients to third party dental laboratories, the ... crowns, implants and dentures in less than one hour. , ... – says Dr. Allred. ”We are constantly investing in the ... the highest quality services.” – He adds. , The newly ...
(Date:4/28/2015)... April 28, 2015 Aultman Hospital ... Advantage (WCA) to transition its outpatient wound center ... hospital’s commitment to the specialty of wound care ... the country currently working with Wound Care ... advanced wound care treatments and hyperbaric oxygen therapy ...
(Date:4/28/2015)... 28, 2015 Consolidated ligations established ... forward nationwide, as courts overseeing proceedings in Louisiana ... According to court documents issued in the U.S. ... status conference in the federal Xarelto litigation will ... C.S.T. (In Re: Xarelto Products Liability Litigation, ...
(Date:4/28/2015)... N.J. (PRWEB) April 28, 2015 Seton Hall ... Kathleen M. Boozang as the new Dean of Seton Hall ... effective July 1, 2015. , Boozang, currently Associate Dean ... Law in 1990. She helped launch and currently directs ... & Policy, ranked a Top 10 law health program ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Returns to Prestigious Quaker Ridge Golf Club in Scarsdale, NY for Annual Golf Invitational 2Health News:Dental Office Upgraded to State of Art Equipment for Dental Implants in San Marcos 2Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 2Health News:Aultman Hospital Transitions Electronic Medical Record for Wound Center with Wound Care Advantage 3Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 3Health News:Seton Hall University Announces Kathleen M. Boozang as New Dean for Law School 2Health News:Seton Hall University Announces Kathleen M. Boozang as New Dean for Law School 3
... strain is similar to that seen in 1918, with ... 24 (HealthDay News) -- The 2009 H1N1 "swine flu" ... early in the 20th century, two teams of scientists ... people seemed to be less affected by H1N1 during ...
... Tuesday, President Obama signed into law U.S. health care ... affect them, their families, and businesses. The ... 2006 legislation in Massachusetts requiring all adults in the ... mandate. A new article from The Milbank Quarterly ...
... , ... Another Group Logic Solution to Their Product Portfolio , ... (PRWEB) March 24, 2010 -- Group Logic, the ... the United Kingdom, Jigsaw Systems, is adding the MassTransit product line to its solution ...
... ... solution will power health information exchange across LSU hospital system for more than 2800 ... ... will be able to access patient information across the 10 rural and metropolitan hospitals ...
... This release is available in Spanish . ... area as the original tumour remains the strongest, independent prognostic ... have been free of disease for a very long time, ... Breast Cancer Conference (EBCC7). Dr Sven Mieog, MD, a ...
... - Despite the aches and pains that occur in old ... positive experiences from their past. A new study, reported ... ( http://www.elsevier.com/locate/cortex ), reveals that older adults, ability to remember ... way in which the brain processes emotional content. In ...
Cached Medicine News:Health News:H1N1 Virus Yields Up More Secrets 2Health News:Massachusetts health care reform reviewed as a model for national plan 2Health News:Jigsaw Systems to Deliver Group Logic's MassTransit Solution for Managed File Transfer 2Health News:Carefx Portal Solution to Deliver First Time, Statewide Access to Patient Data Among Hospitals in the LSU Network 2Health News:Carefx Portal Solution to Deliver First Time, Statewide Access to Patient Data Among Hospitals in the LSU Network 3Health News:Carefx Portal Solution to Deliver First Time, Statewide Access to Patient Data Among Hospitals in the LSU Network 4Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 2Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 3Health News:Older adults remember the good times 2